 - Have received an immunosuppressive biologic agentmonoclonal antibody within 4 half-lives prior to entry, for example, anakinra 4 half-lives18 hours; etanercept 4 half-lives18 days; infliximab; adalimumab 4 half-lives36 days; use of intravenous immune globulin IVIg is permitted. 